000 01278 a2200361 4500
005 20250516062534.0
264 0 _c20120330
008 201203s 0 0 fre d
022 _a1768-3122
024 7 _a10.1016/j.revmed.2011.09.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDrouet, L
245 0 0 _a[Thrombosis and new antithrombotic agents].
_h[electronic resource]
260 _bLa Revue de medecine interne
_cDec 2011
300 _aS236-40 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aChoice Behavior
_xphysiology
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Substitution
_xmethods
650 0 4 _aDrugs, Investigational
_xadministration & dosage
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aThrombosis
_xdrug therapy
700 1 _aMahé, I
700 1 _aLe Gal, G
700 1 _aRighini, M
700 1 _aQuéré, I
773 0 _tLa Revue de medecine interne
_gvol. 32 Suppl 2
_gp. S236-40
856 4 0 _uhttps://doi.org/10.1016/j.revmed.2011.09.011
_zAvailable from publisher's website
999 _c21272139
_d21272139